Article Versions Notes

Rawangkan A, Wongsirisin P, Pook-In G, Siriphap A, Yosboonruang A, Kiddee A, Chuerduangphui J, Reukngam N, Duangjai A, Saokaew S, et al. Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer. Antibiotics. 2022; 11(12):1845. https://doi.org/10.3390/antibiotics11121845

Rawangkan, Anchalee, Pattama Wongsirisin, Grissana Pook-In, Achiraya Siriphap, Atchariya Yosboonruang, Anong Kiddee, Jureeporn Chuerduangphui, Nanthawan Reukngam, Acharaporn Duangjai, Surasak Saokaew, and et al. 2022. "Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer" Antibiotics 11, no. 12: 1845. https://doi.org/10.3390/antibiotics11121845

Rawangkan, A., Wongsirisin, P., Pook-In, G., Siriphap, A., Yosboonruang, A., Kiddee, A., Chuerduangphui, J., Reukngam, N., Duangjai, A., Saokaew, S., & Praphasawat, R. (2022). Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer. Antibiotics, 11(12), 1845. https://doi.org/10.3390/antibiotics11121845